| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.083 | 0.6 |